• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Clear Catheter Systems lands FDA nod for PleuraFlow chest tube-clearing device

Clear Catheter Systems lands FDA nod for PleuraFlow chest tube-clearing device

December 13, 2010 By MedCity News

PleuraFlow

Cleveland Clinic spinoff Clear Catheter Systems, which recently closed a $1.2 million angel investment round, received Food & Drug Administration 510(k) clearance to sell its PleuraFlow Active Tube-Clearance System in the United States.

PleuraFlow keeps catheters clear while draining blood and other fluids from the chest after heart or lung surgery. The device has the potential to improve patient outcomes, said Dr. Edward Boyle, Clear Catheter’s CEO.

“We think this is a product that is going to be a huge breakthrough in managing patients after heart and lung surgery,” Boyle said. “When chest tubes don’t drain well people end up with trouble after surgery.”

MedCity News logo

The device, which already is cleared for sale in Europe and Canada, also could lower healthcare costs by enabling hospitals to increase their efficiency and lower the risk of patient complications — both goals of recent healthcare reform laws.

It could even help doctors better and more safely manage the growing number of patients with a tendency to bleed when they’re put on powerful anti-platelet agents after surgery.

Boyle, a cardiovascular and thoracic surgeon in Oregon, came up with the idea for an active-clearing catheter system while watching his patients endure the discomfort of having large tubes — the patients called them “garden hoses” — inserted in their chests to drain fluid and air after heart or lung surgery.

Worse, the tubes, called catheters, tended to clog. That led to buildup of blood around the heart and lungs, which could lead to complications and even death.

While researching patents on such devices, Boyle found a patent by the Cleveland Clinic’s Dr. Marc Gillinov, also a cardiovascular and thoracic surgeon. The two agreed to work together on PleuraFlow.

The Clinic spun off Clear Catheter Systems, then known as PleuraFlow LLC, in 2007. The company closed its initial round of seed investment (PDF) from the Cleveland Clinic and Bend Venture Angel Investors in August of that year.

A year later, the company raised $600,000 from the Cleveland Clinic-led Global Cardiovascular Innovation Center; Xgen Ltd., a Cleveland investment partnership primarily owned by the family of radio and dot-com mogul Tom Embrescia; and angel investors in Oregon.

During its latest funding cycle, Clear Catheter evaluated more Ohio investment opportunities but decided to go with $1.2 million from a West Coast group led by Oregon Angel Fund, Boyle said. The recent funding brings to $2.2 million the amount the company has raised since its founding. Cleveland Clinic remains a development partner.

Boyle, who had been his company’s sole employee, has hired a global director of sales and marketing to strike relationships with specialty critical care and cardiovascular products distributors. An Arizona company makes the PleuraFlow system.

“This is a huge step for us,” Boyle said. “It positions us so we can begin the commercialization efforts here in the U.S.”

Filed Under: Business/Financial News, News Well, Respiratory Tagged With: Clearflow, Gift Bans

More recent news

  • Neuralink files to raise $649M in new equity offering
  • BofA: Surgical robot remanufacturing not a major setback for Intuitive
  • InspireMD wins CE Mark approval for CGuard Prime
  • Philips reports first cases for VeriSight Pro 3D ICE catheter in Europe
  • Ceryx Medical raises $15M to support bioelectronic pacemaker

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy